Invention Grant
- Patent Title: Quinazoline derivatives for the treatment of cancer diseases
- Patent Title (中): 喹唑啉衍生物用于治疗癌症疾病
-
Application No.: US14739299Application Date: 2015-06-15
-
Publication No.: US09539258B2Publication Date: 2017-01-10
- Inventor: Flavio Solca , Andree Amelsberg , Jacobus C. A. van Meel , Anke Baum , Gerd Stehle
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Philip I. Datlow
- Priority: EP05110656 20051111
- Main IPC: A61K31/517
- IPC: A61K31/517 ; A61K31/553 ; A61K33/24
Abstract:
The present invention relates to the use of quinazolines of formula (I), wherein the groups Ra to Rd have the meanings given in the claims and specification, in cancer therapy.
Public/Granted literature
- US20150272954A1 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES Public/Granted day:2015-10-01
Information query
IPC分类:
